Home/Filings/4/0001104659-23-008079
4//SEC Filing

Burgstahler David F 4

Accession 0001104659-23-008079

CIK 0001739426other

Filed

Jan 29, 7:00 PM ET

Accepted

Jan 30, 5:29 PM ET

Size

7.3 KB

Accession

0001104659-23-008079

Insider Transaction Report

Form 4
Period: 2023-01-27
Burgstahler David F
Director10% Owner
Transactions
  • Other

    Ordinary Shares

    2023-01-271,032,9950 total(indirect: By Avista Capital investment fund)
Holdings
  • Ordinary Shares

    (indirect: By Avista Capital investment fund)
    23,730,864
Footnotes (3)
  • [F1]Represents shares distributed in kind by Orbit Co-Invest III LLC ("Orbit III") to its members, on a pro rata basis, for no consideration.
  • [F2]Represents shares of the Issuer held by Orbit III. Avista Capital Partners III GP, L.P. ("ACP GP") is the manager of Orbit III. Mr. Burgstahler is a member of the investment committee of ACP GP. By virtue of this relationship, Mr. Burgstahler may be deemed to have shared voting and investment power with respect to the shares held by Orbit III. Mr. Burgstahler disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
  • [F3]Represents shares of the Issuer held by Avista Healthcare Partners, L.P. ("AHP"). Avista Healthcare Partners GP, Ltd. ("AHP GP") is the general partner of AHP. Mr. Burgstahler is a member of the investment committee of AHP GP. By virtue of this relationship, Mr. Burgstahler may be deemed to share voting and investment power with respect to the shares held by AHP. Mr. Burgstahler disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.

Issuer

RVL Pharmaceuticals plc

CIK 0001739426

Entity typeother

Related Parties

1
  • filerCIK 0001374179

Filing Metadata

Form type
4
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 5:29 PM ET
Size
7.3 KB